I migliori medici di Mammografia in Israele — TOP-8 medici

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Il medico è un gastroenterologo e ematologo di spicco con oltre 50 anni di esperienza, specializzato in condizioni epatiche. Il medico è riconosciuto come un esperto leader del fegato presso l'Ichilov Medical Center, concentrandosi sul trattamento e la diagnosi di epatite cronica, malattie autoimmuni e genetiche del fegato.<\/p>

Il medico dirige l'Unità Fegato presso il Sourasky Medical Center e ha una laurea in medicina dall'Università Ebraica e una specializzazione in gastroenterologia dalla Scuola di Medicina Hadassah dell'Università Ebraica. Il medico ha scritto oltre 60 pubblicazioni e ha presentato in 100 conferenze.<\/p>

Le adesioni includono l'Associazione Israeliana di Gastroenterologia e le Associazioni Americana ed Europea per lo Studio del Fegato.<\/p>

Il medico si è laureato presso la Facoltà di Medicina del Technion e ha completato un tirocinio presso l'Istituto di Visualizzazione, Centro Medico Tel Aviv Sourasky. Specializzandosi in radiologia diagnostica, il medico si è ulteriormente specializzato in imaging mammario presso l'Istituto di Mammografia, Centro Medico di Tel Aviv. La formazione aggiuntiva include la risonanza magnetica della ghiandola mammaria presso l'Istituto Curie, Parigi, e le tecnologie avanzate di imaging mammario presso il Centro Oncologico Gustave Roussy, Francia.<\/p>

Dal 2013, il medico è Direttore del Dipartimento di Mammografia presso il Centro Medico di Tel Aviv ed è consulente per Maccabi HMO. Il medico è attivamente coinvolto nell'educazione all'imaging mammario presso l'Università di Tel Aviv ed è membro di diverse associazioni professionali.<\/p>

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Il medico è un mammologo altamente esperto, specializzato in chirurgia mammaria. Con un focus su tecniche chirurgiche innovative, il medico guida il Dipartimento di Chirurgia Mammaria, garantendo cure e risultati di alto livello per i pazienti. Il medico è riconosciuto per i suoi contributi al trattamento del cancro al seno e ha pubblicato numerosi articoli di ricerca su riviste mediche prestigiose. Il medico è anche coinvolto in studi clinici mirati a migliorare le terapie per il cancro al seno e ha ricevuto numerosi premi per l'eccellenza nella pratica chirurgica e nella cura del paziente.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.